Financial barriers and perceived implicit biases were both barriers that families of children with acute leukemia raised regarding access to care issues that might have delayed diagnosis, said Lena Winestone, MD, assistant professor of pediatrics at the University of California, San Francisco.
Financial barriers and perceived implicit biases were both barriers that families of children with acute leukemia raised regarding access to care issues that might have delayed diagnosis, said Lena Winestone, MD, assistant professor of pediatrics at the University of California, San Francisco.
Transcript
What did the interviews you conducted reveal about access to care and how it might influence disparities among children with acute leukemia?
Yeah, so in the interviews that we conducted, families identified a variety of different barriers to care. But some of the ones that really jumped out to us were the financial barriers. So, several families said that they either took longer to go to their primary care doctor, or that [financial costs] was involved in the decision making about whether they went to the primary care doctor versus an urgent care versus an emergency room. Their type of insurance and the co-pays associated with that really determined how they chose to navigate the health system and get the care that they ultimately receive. And we think that that probably has implications for the timeliness of their diagnosis.
In addition, there were some suggestions of sort of interactions between the provider and patient that were less than optimal. And we're sort of continuing to work to tease apart whether that could be related to some racial implicit bias. And, you know, some patients at least felt as if their provider treated them differently, either because of their age or because of their race, or because of their ethnicity, or because of language barriers. And so those pieces are ongoing investigation to understand exactly what barriers particularly our impoverished patients and our minority patients face.
Balancing Cost and Quality in Oncology: A Value-Based Care Perspective
January 30th 2025Travis Brewer, vice president of payer and public health strategy/relations at Texas Oncology, shared that value-based oncology care can achieve both cost efficiency and high-quality outcomes through integrated multidisciplinary teams, flexible payment models, and targeted treatment approaches.
Read More
Unlocking Access: Exploring Mental Health Care Among Medicaid Managed Care Enrollees
January 23rd 2025On this episode of Managed Care Cast, we speak with the author of a study published in the January 2025 issue of The American Journal of Managed Care® to examine the association between quantitative network adequacy standards and mental health care access among adult Medicaid enrollees.
Listen
How FcRn Blockade Targets Myasthenia Gravis Autoantibodies
January 29th 2025In part 2 of our interview with Katie Abouzahr, MD, Johnson & Johnson Innovative Medicine, we discuss the challenge inherent in treating adolescents who have the myasthenia gravis and how nipocalimab works via FcRn blockade to reduce the circulating autoantibodies that drive myasthenia gravis.
Read More